![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Endocrinol. , 31 January 2025
Sec. Clinical Diabetes
Volume 16 - 2025 | https://doi.org/10.3389/fendo.2025.1418357
Objectives: In the early stages of various critical infections and diseases, altered association of cortisol and adrenocorticotropic hormone (ACTH) levels occurs, with cortisol levels increasing and ACTH levels remaining normal or decreasing. This study aimed to explore the relationship between ACTH and cortisol levels in patients with diabetic ketoacidosis (DKA) and the influence of the severity of DKA.
Methods: A total of 106 type 2 diabetes patients with DKA admitted to the Endocrinology Department of Yantai Yuhuangding Hospital from February 2018 to May 2023 were divided into groups without (n=54) and with bacterial infection (n=52). Twenty type 2 diabetes patients without infection or DKA admitted during the same period were included as the control group. Cortisol and ACTH levels were measured on the first day of admission and the day after DKA correction for patients with DKA and on the first day of admission and the day before discharge for the control group.
Results: Compared with the control group, the DKA groups both with and without infection had significantly higher cortisol levels (P<0.05) and significantly lower ACTH levels (P<0.01) at admission. DKA patients with infection had significantly higher cortisol levels at admission than those without infection (734.51 ± 348.69 nmol/L vs 508.79 ± 268.72 nmol/L, P<0.01), while ACTH levels did not differ significantly between the two groups (P>0.05). After correction of DKA, no differences in cortisol or ACTH levels were observed among the three groups. Compared with levels at admission, DKA patients both with and without infection had lower cortisol levels and higher ACTH levels after DKA correction (all P<0.001). Multiple stepwise regression analysis showed that for all DKA patients and for subgroups with and without infection, the cortisol level at admission was independently positively correlated with the ACTH level and negatively correlated with the bicarbonate level (both P<0.01).
Conclusions: In the early stage of DKA, a phenomenon of altered association between cortisol–ACTH occurs and is especially prominent in DKA patients with infection. This altered association between cortisol–ACTH disappears after DKA correction, and the severity of DKA is an independent influencing factor on the cortisol level in early-stage DKA.
Diabetic ketoacidosis (DKA) is a clinical syndrome of hyperglycemia, ketosis, and anion gap metabolic acidosis caused by abnormal metabolism of glucose, fat, and protein due to insufficient insulin levels or an increased level of insulin antagonist hormone. DKA remains one of the most frequently occurring diabetes-related emergencies, and despite advances in diabetes management and increased standardization of care, is still associated with appreciable morbidity and mortality (1, 2). Research has confirmed that infections, stress, and trauma are important triggers for DKA (2, 3). Cortisol is an important stress hormone that is secreted by the adrenal cortex and regulated by the hypothalamic pituitary adrenal (HPA) axis (4, 5). Under stress conditions, the HPA axis is activated, leading to increases in the levels of both cortisol and adrenocorticotropic hormone (ACTH), and this activation represents an important mechanism for adapting to stress and maintaining a stable internal environment. Previous studies have illustrated a close correlation between elevated cortisol levels and the severity of disease in multiple illness and stress states (6–8). However, an increasing number of animal and human studies in recent years have shown that in the early stages of critical illness, infections, and other diseases, altered association of cortisol and ACTH levels occurs that is characterized by increased cortisol levels and normal or decreased ACTH levels. Research related to this phenomenon has mainly focused on individuals hospitalized in an intensive care unit (ICU) and experiencing sepsis and/or shock (9–14). Changes in serum cortisol and ACTH levels during the onset of DKA have been rarely investigated.
The present study aimed to investigate the changes in cortisol and ACTH levels in patients with DKA as well as the potential mechanisms of these changes. The results provide important supplementary and reference value for the clinical diagnosis and treatment of DKA and further in-depth research on the phenomenon of altered cortisol–ACTH association.
A total of 106 type 2 diabete mellitus (T2DM) patients with DKA admitted to the Endocrinology Department of Yantai Yuhuangding Hospital from February 2018 to May 2023 were included. The inclusion criteria were as follows: 1) diagnosed with DKA (15) based on blood glucose >11 mmol/L with a positive result for blood ketone or urine ketone; low blood pH (<7.3) or low blood bicarbonate (<15 mmol/L); 2) aged 18–75 years; and 3) no history of treatment for DKA before admission. The exclusion criteria included: 1) presence of another acute complication of diabetes; 2) diagnosis of gestational diabetes or another special type of diabetes; 3) conditions affecting HPA axis function, including adrenal cortical insufficiency or Cushing’s syndrome; severe liver or kidney dysfunction; treatment with exogenous glucocorticoids or any drug affecting the HPA axis; mental disorders or central nervous system diseases; 4) autoimmune diseases; and 5) malignant tumors.
All DKA patients were divided into two groups without bacterial infection (n=54) and with bacterial infection (n=52) based on the presence or absence of bacterial infection. The evaluation of bacterial infection included: 1) evidence of infection detected through analysis of blood, body fluids, or auxiliary examinations; 2) each patient’s clinical manifestations, routine blood test results, C-reactive protein level, and procalcitonin level. Twenty T2DM patients without infection or DKA admitted during the same time period served as the control group. This study was approved by the Ethics Committee of Yantai Yuhuangding Hospital. All patients provided written informed consent before participation.
Venous blood was collected at admission for DKA before the start of treatment to measure blood glucose and bicarbonate levels. On the morning after admission, fasting blood samples were collected for measurement of albumin, blood lipid profile [total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-c), low-density lipoprotein cholesterol (LDL-c)], glycated hemoglobin (HbA1c), alanine aminotransferase (ALT), and serum creatinine. Venous blood was collected for electro-chemiluminescence to determine cortisol and ACTH levels at 8:00 am on the day after admission and 8:00 am on the day after DKA correction (Cobas e601; Roche, Switzerland) for all patients with DKA and at 8:00 am on the day after admission and 8:00 am on the day before discharge for the control group. Body mass index was calculated as follows: BMI = weight (kilogram)/height2 (m2).
Statistical analyses were performed using SPSS 16.0. Data for all variables were tested for normality. Skewed distributed variables are represented as median (interquartile range), and normally distributed variables are represented as mean ± standard deviation (SD). Student’s t–test or analysis of variance was performed to compare data between or among groups for variables with a normal distribution, whereas the Mann-Whitney U-test or Kruskal–Wallis test was used to compare variables with a skewed distribution. The χ2 test was applied to detect differences in categorical variables among the groups. Comparison of cortisol and ACTH levels before and after DKA correction was performed using the independent sample t-test and two related sample tests. Multiple stepwise regression analysis was conducted to identify the factors that influenced the serum cortisol level.
A total of 20 T2DM patients without DKA and 106 T2DM patients with DKA were included in this study. As shown in Table 1, compared with the control group, patients with DKA had higher blood glucose and lower levels of age and bicarbonate (all P<0.05). No significant differences were observed in gender, BMI, systolic blood pressure (SBP), diastolic blood pressure (DBP), HbA1c, albumin, TC, TG, LDL-c, HDL-c, ALT, and serum creatine (all P>0.05). In addition, compared with the DKA without infection group, the DKA with infection group had lower levels of bicarbonate (6.78 ± 3.73 mEq/L vs 9.45 ± 4.35 mEq/L, P=0.001) and albumin (33.03 ± 4.87 g/L vs 36.22 ± 4.82 g/L, P=0.001, while gender, age, SBP, DBP, blood glucose, HbA1c, TC, TG, LDL-c, HDL-c, ALT, and blood creatinine showed no statistically significant differences between the two groups (all P>0.05).
As shown in Figure 1A, the cortisol level in the DKA groups both with and without infection was significantly higher than that in the control group at admission (all P<0.05), and the cortisol level in the DKA with infection group was significantly higher than that in the DKA without infection group at admission (734.51 ± 348.69 nmol/L vs 508.79 ± 268.72 nmol/L, P<0.001). The cortisol levels after DKA correction in DKA patients and on the day before discharge in the control group showed no significant difference among the three groups (all P>0.05, Figure 1B). As shown in Figure 2A, the ACTH level in the DKA groups both with and without infection was significantly lower than that in the control group at admission (all P<0.01), while the ACTH levels did not differ between the two DKA groups (P>0.05). As shown in Figure 2B, no difference in ACTH levels was observed after DKA correction (DKA patients) or the day before discharge (control group) among the three groups (all P>0.05).
Figure 1. Comparison of cortisol levels among groups and at different time points. (A) Cortisol at admission; (B) Cortisol after correction of DKA (or day before discharge for controls).
Figure 2. Comparison of ACTH levels among groups and at different time points. (A) ACTH at admission; (B) ACTH after correction of DKA (or day before discharge for controls).
Compared with the levels at admission, the DKA groups both with and without infection showed a decrease in cortisol level and an increase in ACTH level after DKA correction (all P<0.001; Table 2).
For the multiple stepwise regression analysis, cortisol level was set as the dependent variable, and the independent variables included age, gender, BMI, HbA1c, blood glucose at admission, ACTH at admission, bicarbonate, albumin, blood lipid levels, ALT, blood creatinine, and presence of infection. Multiple stepwise regression showed that the cortisol level at admission was independently positively correlated with the ACTH level at admission (standardized β=0.354, P<0.001), the presence of infection (standardized β=0.226, P=0.005), DBP (standardized β=0.219, P=0.003), and blood glucose at admission (standardized β=0.208, P=0.006), and independently negatively correlated with the bicarbonate level (standardized β=-0.341, P<0.001).
Further subgroup analysis showed that the cortisol level at admission was positively correlated with the ACTH level at admission (DKA without infection group, standardized β=0.286, P=0.003; DKA with infection group, standardization β=0.337, P=0.002) and independently negatively correlated with the bicarbonate level (DKA without infection group, standardized β=-0.367, P<0.001; DKA with infection group, standardization β=-0.489, P<0.001). In the DKA without infection group, the cortisol level at admission was independently positively correlated with the creatinine level at admission. In the DKA with infection group, the cortisol level at admission was independently positively correlated with DBP, ALT, and blood glucose at admission (all P<0.05; Table 3).
The results of the present study indicate that in the early stage of DKA, the phenomenon of altered cortisol–ACTH association exists and is especially prominent in DKA patients with bacterial infection. The altered association of cortisol and ACTH levels disappeared after correction of DKA in these patients. Also, the severity of DKA, as represented by the bicarbonate level, was an independent influencing factor for the cortisol level in the early stage of DKA.
The study of the adrenal cortex axis in patients with critical illness has always received widespread attention, and patients included in previous studies tended to have hypercortisolemia, which is directly proportional to the severity of disease (16, 17). The present study found that in cases both with and without bacterial infection, the cortisol level was significantly increased in the early stages of DKA, and the cortisol level increased with increasing severity of DKA (represented by a greater decrease in bicarbonate), consistent with previous research results in patients with critical illness. It has been widely recognized in previous studies that high plasma cortisol levels in patients with critical illness are driven by increased synthesis of corticotropin-releasing hormone, ACTH, and arginine vasopressin (6, 18), and our study also found that the cortisol level increased with increasing ACTH level in the early stage of DKA. In recent years, numerous studies have reported an altered association of ACTH and cortisol levels in stress disease states of non-critical diseases other than sepsis (19), including chronic obstructive pulmonary disease, the inflammatory response, and psychiatric disorders (12, 20–22), suggesting the existence of another mechanism for the maintenance of high glucocorticoid levels in addition to ACTH.
As early as 1995, Vermes et al. (19) found that in critically ill patients, the ACTH level only briefly increases, while the cortisol level remains consistently high. Boonen et al. (14) reported that among patients admitted to the ICU, the plasma ACTH level remained consistently low from day 1 to week 1 after admission, while the plasma total cortisol and free cortisol levels remained high over this period. Another study on burn patients found that the plasma cortisol concentration increased proportionally to the burn area, while the plasma ACTH level did not increase (13). In patients undergoing cardiac surgery, plasma ACTH and cortisol levels begin to rise shortly after surgery, but ACTH quickly decreases while plasma cortisol can remain high (23). A recent meta-analysis on coronavirus disease 2019 (COVID-19), including 440 patients with COVID-19 and 474 control subjects, found significantly higher cortisol levels in COVID-19 patients compared with controls, but no significant difference in ACTH levels (24). In addition, the phenomenon of cortisol–ACTH dissociation was observed in a mouse model of sepsis (25). The present study also observed the cortisol–ACTH altered association in the early stages of DKA, and this cortisol-ACTH altered association disappeared after the correction of DKA.
The mechanism of altered cortisol-ACTH association remains unclear. Some studies have shown that increased production and decreased decomposition of cortisol in critically ill patients leads to hypercortisolemia. Marik et al. (10) found that patients with systemic inflammatory response syndrome (SIRS) have an increased rate of cortisol production while the ACTH level is decreased. They also reported a lower degree of cortisol response under exogenous ACTH stimulation, while pro-inflammatory factors tumor necrosis factor alpha and interleukin 6 show a positive correlation with cortisol production, suggesting that these cytokines may be driving factors for increased cortisol production during critical illness. Some studies also found that elevated cortisol levels in patients with critical illness may be the result of reduced cortisol clearance. The liver and kidney are the main sites for cortisol clearance. A-ring reductase (5β-reductase and 5α-reductase) and 11 β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) play an important role in cortisol metabolism (26, 27). Boonen et al. (14) confirmed that the increase in blood cortisol in patients with critical illness is mainly caused by a decrease in cortisol clearance rather than an increase in cortisol production and confirmed that the decrease in cortisol clearance is related to lower expression and reduced activity of A-ring reductase and 11β-HSD2. The present study also found that serum creatinine and ALT levels were independent factors positively correlated to the increased cortisol level in patients with DKA. We speculate that the increase in cortisol during DKA is partially caused by abnormal liver and kidney function leading to a decrease in cortisol clearance.
Although an altered cortisol-ACTH association has been commonly observed in patients with critical illness, research has suggested that only the plasma cortisol level is associated with disease severity, while the ACTH level is not associated with disease severity (13). In the present study, an independent association was also found between the high cortisol level and low bicarbonate level in DKA patients.
The present study has several limitations to consider. First, the sample size was relatively small for drawing robust conclusions. Second, the single-center design may have resulted in selection bias. In our future research, we will expand the sample size and conduct a mechanistic study to validate the conclusions of this study.
In conclusion, the results of this study provide evidence that in the early stage of DKA, a phenomenon of altered cortisol–ACTH association exists, which then disappears after correction of DKA. The severity of DKA (as represented by the bicarbonate level) is an independent influencing factor for the cortisol level in the early stage of DKA. Compared to other critical illnesses, DKA has fewer influencing factors. Therefore, these findings are of great significance for the in-depth study of the mechanism of altered cortisol-ACTH association.
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
The studies involving humans were approved by the Ethics Committee of Yantai Yuhuangding Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.
LW: Conceptualization, Writing – original draft. XM: Data curation, Formal analysis, Writing – review & editing. YT: Investigation, Methodology, Writing – review & editing. YH: Conceptualization, Writing – review & editing.
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
We thank Medjaden, Inc. for scientific editing of this manuscript.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
1. Pasquel FJ, Messler J, Booth R, Kubacka B, Mumpower A, Umpierrez G, et al. Characteristics of and Mortality Associated with Diabetic Ketoacidosis among Us Patients Hospitalized with or without Covid-19. JAMA Netw Open. (2021) 4:e211091. doi: 10.1001/jamanetworkopen.2021.1091
2. Islam T, Sherani K, Surani S, Vakil A. Guidelines and controversies in the management of diabetic ketoacidosis - a mini-review. World J Diabetes. (2018) 9:226–9. doi: 10.4239/wjd.v9.i12.226
3. Calimag APP, Chlebek S, Lerma EV, Chaiban JT. Diabetic ketoacidosis. Dis Mon. (2023) 69:101418. doi: 10.1016/j.disamonth.2022.101418
4. Teblick A, Peeters B, Langouche L, Van den Berghe G. Adrenal function and dysfunction in critically ill patients. Nat Rev Endocrinol. (2019) 15:417–27. doi: 10.1038/s41574-019-0185-7
5. Van den Berghe G, Teblick A, Langouche L, Gunst J. The hypothalamus-pituitary-adrenal axis in sepsis- and hyperinflammation-induced critical illness: gaps in current knowledge and future translational research directions. EBioMedicine. (2022) 84:104284. doi: 10.1016/j.ebiom.2022.104284
6. Vermes I, Beishuizen A. The hypothalamic-pituitary-adrenal response to critical illness. Best Pract Res Clin Endocrinol Metab. (2001) 15:495–511. doi: 10.1053/beem.2001.0166
7. Widmer IE, Puder JJ, Konig C, Pargger H, Zerkowski HR, Girard J, et al. Cortisol response in relation to the severity of stress and illness. J Clin Endocrinol Metab. (2005) 90:4579–86. doi: 10.1210/jc.2005-0354
8. Mesotten D, Vanhorebeek I, Van den Berghe G. The altered adrenal axis and treatment with glucocorticoids during critical illness. Nat Clin Pract Endocrinol Metab. (2008) 4:496–505. doi: 10.1038/ncpendmet0921
9. Teblick A, De Bruyn L, Van Oudenhove T, Vander Perre S, Pauwels L, Derde S, et al. Impact of hydrocortisone and of crh infusion on the hypothalamus-pituitary-adrenocortical axis of septic male mice. Endocrinology. (2022) 163:bqab222. doi: 10.1210/endocr/bqab222
10. Marik PE, Annane D. Reduced cortisol metabolism during critical illness. N Engl J Med. (2013) 369:480–1. doi: 10.1056/NEJMc1306703
11. Peeters B, Meersseman P, Vander Perre S, Wouters PJ, Vanmarcke D, Debaveye Y, et al. Adrenocortical function during prolonged critical illness and beyond: A prospective observational study. Intensive Care Med. (2018) 44:1720–9. doi: 10.1007/s00134-018-5366-7
12. Bornstein SR, Engeland WC, Ehrhart-Bornstein M, Herman JP. Dissociation of acth and glucocorticoids. Trends Endocrinol Metab. (2008) 19:175–80. doi: 10.1016/j.tem.2008.01.009
13. Vaughan GM, Becker RA, Allen JP, Goodwin CW Jr., Pruitt BA Jr., Mason AD Jr. Cortisol and corticotrophin in burned patients. J Trauma. (1982) 22:263–73. doi: 10.1097/00005373-198204000-00001
14. Boonen E, Meersseman P, Vervenne H, Meyfroidt G, Guiza F, Wouters PJ, et al. Reduced nocturnal acth-driven cortisol secretion during critical illness. Am J Physiol Endocrinol Metab. (2014) 306:E883–92. doi: 10.1152/ajpendo.00009.2014
15. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. (2009) 32:1335–43. doi: 10.2337/dc09-9032
16. Ho JT, Al-Musalhi H, Chapman MJ, Quach T, Thomas PD, Bagley CJ, et al. Septic shock and sepsis: A comparison of total and free plasma cortisol levels. J Clin Endocrinol Metab. (2006) 91:105–14. doi: 10.1210/jc.2005-0265
17. Dalegrave D, Silva RL, Becker M, Gehrke LV, Friedman G. Relative adrenal insufficiency as a predictor of disease severity and mortality in severe septic shock. Rev Bras Ter Intensiva. (2012) 24:362–8. doi: 10.1590/s0103-507x2012000400012
18. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev. (1998) 19:101–43. doi: 10.1210/edrv.19.2.0326
19. Vermes I, Beishuizen A, Hampsink RM, Haanen C. Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab. (1995) 80:1238–42. doi: 10.1210/jcem.80.4.7714094
20. Kennis M, Gerritsen L, van Dalen M, Williams A, Cuijpers P, Bockting C. Prospective biomarkers of major depressive disorder: A systematic review and meta-analysis. Mol Psychiatry. (2020) 25:321–38. doi: 10.1038/s41380-019-0585-z
21. Cornil A, Glinoer D, Leclerco R, Copinschi G. Adrenocortical and somatotrophic secretions in acute and chronic respiratory insufficiency. Am Rev Respir Dis. (1975) 112:77–81. doi: 10.1164/arrd.1975.112.1.77
22. Pascualy M, Petrie EC, Brodkin K, Peskind ER, Wilkinson CW, Raskind MA. Hypothalamic pituitary adrenocortical and sympathetic nervous system responses to the cold pressor test in alzheimer's disease. Biol Psychiatry. (2000) 48:247–54. doi: 10.1016/s0006-3223(00)00879-9
23. Gibbison B, Spiga F, Walker JJ, Russell GM, Stevenson K, Kershaw Y, et al. Dynamic pituitary-adrenal interactions in response to cardiac surgery. Crit Care Med. (2015) 43:791–800. doi: 10.1097/CCM.0000000000000773
24. Cai Z, Liu B. Unraveling the relationship between acth and cortisol levels in covid-19 infections: A meta-analysis. PloS One. (2023) 18:e0296281. doi: 10.1371/journal.pone.0296281
25. Teblick A, Vander Perre S, Pauwels L, Derde S, Van Oudenhove T, Langouche L, et al. The role of pro-opiomelanocortin in the acth-cortisol dissociation of sepsis. Crit Care (London England). (2021) 25:65. doi: 10.1186/s13054-021-03475-y
26. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, et al. 11beta-hydroxysteroid dehydrogenase type 1: A tissue-specific regulator of glucocorticoid response. Endocr Rev. (2004) 25:831–66. doi: 10.1210/er.2003-0031
Keywords: diabetes ketoacidosis, infection, bicarbonate, cortisol, altered cortisol ACTH association
Citation: Wang L, Meng X, Tang Y and Hao Y (2025) Altered association between cortisol and adrenocorticotropic hormone levels in the early stage of type 2 diabetic ketoacidosis. Front. Endocrinol. 16:1418357. doi: 10.3389/fendo.2025.1418357
Received: 16 April 2024; Accepted: 15 January 2025;
Published: 31 January 2025.
Edited by:
David Torpy, Royal Adelaide Hospital, AustraliaCopyright © 2025 Wang, Meng, Tang and Hao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yaping Hao, YWRyaWF0aWNzZWFAMTYzLmNvbQ==
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.